USSTOCK.TODAY
Market Closed
Log in Sign up

Leerink Partners sets $8 price target for Zentalis Pharmaceuticals

InvestorsHub +1 ·

ZNTL
ZNTL Zentalis Pharmaceuticals Inc
$2.78 +10.32%
View chart & analysis →
  1. 1Zentalis Pharmaceuticals shares rose 4.4% in premarket trading.
  2. 2Leerink Partners' $8 price target is higher than the previous $4 target.
  3. 3The 12-month average analyst price target was set at approximately $6.75.

So what's the key point?

Leerink Partners set a price target of $8 for Zentalis Pharmaceuticals, suggesting the stock price will rise further. This figure is higher than the price expected by other experts.

Source InvestorsHub +1 · View original ↗

Related 3-line summaries

CFTC Proposes Regulatory Framework for Leveraged Crypto Asset Trading for Retail Investors Investing.com +1 · 5h ago3 Blue-Chip Dividend Stocks That Have Never Cut Their Dividends The Motley Fool +1 · 5h agoStarbucks faces class action lawsuit over alleged false labeling of sugar content in protein drinks Quartz +1 · 5h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news